Nasdaq
URGN
UroGen Pharma Ltd.
- Health Care
- Israel
- Listed 2017
- 1 day
- −1.8%
- 1 month
- +20.8%
- 1 year
- +128%
$45.60 · Mkt cap $2.22B
At the 6 Aug 2026 close
Nasdaq
UroGen Pharma Ltd.
$45.60 · Mkt cap $2.22B
At the 6 Aug 2026 close
UroGen Pharma Ltd. trades under the ticker URGN on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2017. Its market capitalisation is $2.22B. The last closing price was $45.60, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +128%, and +20.8% over the past month. Returns are price returns and exclude dividends.
This page exists because URGN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.